2[1]OReilly M,Newcomb DE,Remick D,et al.Endotoxin,sepsis,and the primarily path[J].Shock,1999,12 (6):411-420.
3[2]Bone RC.The pathogenesis of sepsis[J].Ann Intern Med,1991,115(6):457-469.
4[3]Staff M,Weintraub A,Widmalm G,et al.Structure determination of the o-antigenic polysacchanide from the enteroinvasive Escherichia coli 1036[J].Eur J Biochem,1999,263(3):656.
5[4]Ebihara I,Nakamura T,Shimada N,et al.Effect of hemoperfision with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis[J].Am J Kidney Dis,1998,32(6):953-961.
6[5]Aoki H,Kodama M,Tani T,et al.Treament of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fibe[J].Am J Surg,1994,167(4):412.
7[6]Mayumi T,Takezawa J,Takahashi H,et al.Low-dose intramuscular polymyxin B improve survival of septic rats[J].Shock,1999,11 (2):82-86.
8[7]Mittergger R,White A,Weber C,et al.In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment[J].Ther APHER,1999,3 (3):257.
9[8]Hoffmann JN,Hartl WH,Deppisch R,et al.Hemofiltration in human sepsis:evidence for elimination of immunodulatory substances[J].Kidey Int,1995,48(6):1563-1570.
10[9]Marks DH,Medina F,Hou KC,et al.Efficacy of antibacterial membrane and effect on blood components[J].Milit Med,1988,153(7):337-339.
7Agarwal R.Hypcrtcnsion and in chronic hcmodialysis patiants-past lessons and future opportmtities [J].Kidney 1nt,2005;67( 1 ): 1 - 13.
8Takcds A,Toda T, Fujii T,et al.Discordancc of influence of hypertension on mortality and cardiovascular risk in hcmodialysis paticnts[J].Am J Kidney Dis,2005;45( 1 ): 112-118.
